FORMULATION AND EVALUATION OF TASTE MASK ORALLY DISPERSIBLE PARACETAMOL TABLET
Mostly the drugs are administered by oral route. Orally dispersible tablets are achieving importance when compared to novel oral drug delivery system. Orodispersible tablets are suitable for all age patients by masking the taste of drug. The objective of the present study was to optimize, formulate and evaluate orally dispersible tablet (ODT) of Paracetamol which disintegrates within few seconds in presence of saliva fluid by the use of super disintegrants. Â Paracetamol is widely used over-the counter analgesic (pain reliever) and antipyretic (fever reducer). It is a very bitter drug so the patients unable to take orally; hence their bitter taste were masked. ODTs Formulations were prepared by Direct Compression and wet granulation method by the use of superdisintegrants and taste masking (F7;F8) is done by Eudragit EPO. The developed formulations were evaluated in terms of weight variation, drug content, friability, thickness, hardness, disintegration and in vitro dissolution test. Stability study of optimized formulation was also carried out as per ICH guidelines. The effects of disintegrants as well as binders in different concentration on the release profile of paracetamol ODTs were studied. The studied parameters were found to be satisfactory for all formulations. Disintegration time for the formulations was found to be less than 40 seconds. Disintegration time for all ODTs decreased with increase in disintegrant concentration. ODTs prepared using Avicel possessed least disintegration time (11s), offered better dissolution profile than that of all the ODTs formulations. Accelerated studies proved that the optimized formulation was stable even after three months.
Keywords: Orodispersible tablets, Paracetamol, Prosolv ODT; Eudragit EPO, physical characterization. in-vitro dissolution,
3. ITANMOY GHOSH*, AMITAVA GHOSH AND DEVI PRASAD, A review on new generation orodispersible tablets and its future prospective. International Journal of Pharmacy and Pharmaceutical Sciences, 2011; 3(1):1-7.
4. Chotaliya MB, Chakraborty S, Overview of Oral Dispersible Tablets. International Journal of PharmTech Research, 2012,4(4),1712-20.
5. Pokhariya P, Ganarajan G, Kothiyal P, MOUTH DISSOLVING TABLET: REVIEW,2015, 4(11), 750-767.
6. Garg A, Gupta MM, Taste masking and formulation development & evaluation of mouth dissolving tablets of levocetrizine dihydrochloride, Journal of Drug Delivery & Therapeutics, 2013, 3(3), 123-130.
9. Danagi PM, Halakatti PK, Mastiholimath VM, Patil M.B, Manvi FV, Rapidly disintegrating domperidone tablets. Indian Drugs 2006, 43(7), 594-97.
10. Shishu, Bhatti A, Singh T. Preparation of tablets rapidly disintegrating in saliva containing bitter taste masked granules by compression method. Indian Journal of Pharmaceutical Sciences, 2007, 69(1), 80-84.
11. Jadon RS, Nayak S, Amlan S, Vaidya VD, Khemariya P, Sumbhate S, Nayak S, Taste masking of Lornoxicam by polymer carrier system and formulation of oral disintegrating tablets, International Journal of Drug Delivery, 2009, 1, 27-31.
12. Sreenivas SA, Gadad AP. Formulation and evaluation of Ondancetron Hcl directly compressed mouth disintegrating tablets. Indian Drugs, 2006, 43(1), 35-38.
13. Bi Y, Sunanda H, Yonezawa Y, Danjo K, Otsuka A, Iida K. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chemical and Pharmaceutical Bulletin, 1996, 44, 2121-2127.
14. Reddy LH, Gosh BR. Fast dissolving drug delivery system: A Review of the literature. Indian Journal of Pharmaceutical Sciences, 2002, 64,331-336.
15. Narazaki R, Harada T, Takami N, Kato Y, Ohwaki T, A new method for disintegration studies of rapid disintegrating tablet.Chemical & Pharmaceutical Bulletin (Tokyo). 2004, 52(6), 704-7.
16. Bandari S, Mittapalli RK, Gannu R, Rao YM. Orodispersible tablets: An overview. Asian Jornal of Phamacutics. 2008,2, 2â€“11.
17. Paramita Dey and Sabyasachi Maiti. Orodispersible tablets: A new trend in drug delivery. Journal of Natural Science Biology and Medcine. 2010 Jul-Dec; 1(1): 2â€“5.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).